Cidara Therapeutics Stock

Cidara Therapeutics soared to nearly a decade high on Friday, as investors gobbled up shares following news that it is set to be acquired by pharmaceutical giant Merck for $9.2 billion. At intra-day trading, Cidara Therapeutics, Inc. （NASDAQ:CDTX） soared to... Read more